Studies indicate that ingested oral cyanocobalamin tablets are ineffective in the treatment of allergic disease, perhaps because once ingested, they are directly metabolized in nutritional supplement suppliers the liver. when b12 is delivered via injection or lozenge it passes throughout the bloodstream before arriving at the liver. it is during this first pass in its native form that it is believed to exert its therapeutic effect. clinical research: "the world health organization (who) recognizes allergic rhinitis (hay fever), sinusitis, asthma,...conjunctivitis, urticaria, eczema, dermatitis (contact and atopic)...allergic supplement and suppliers and migraine headache...as diseases in which ige-mediated allergy may be involved."1 in 1988, asthma and allergic rhinitis subjects were treated with b12. total ige, specific ige and pulmonary lung functions were taken at days 45, 150 and 180 from baseline. eight of the 9 subjects had reduced nutritional supplements info ige. 2 in 1989 open label studies at two sites in riverside county, ca in 1989. sixteen of the 17 subjects had lowered ige levels from day 0 to day 30.3

with no further treatment, the 1996 ten-month follow-up data (n=92) from a high pollen period in oregon, washington and idaho together showed a greater reduction in the active group (n=43) than the placebo group (n=49) on the primary endpoint, defined as a combination supplement of symptom and rescue medication scores.8 patients gave blood serum samples prior to the treatment in 1995 and one year later in 1996. they were immunoassayed for specific ige antibodies using a chemi-luminescent technique. statistician bradley rosebrook ran t-tests suppliers comparing average baseline ige levels to one-year. for the seasonal allergens reported, the active group (n=27) had on average a greater reduction in ige than the placebo group (n=34) for 13 out of 16 allergens.8

in 1990 study in san diego, ca the 5 active subjects with allergic rhinitis had a lowered nutritional supplements total serum ige from day 0 to day 90 while 4 placebo subjects, (2 with allergic rhinitis, 1 with asthma supplement and 1 with both), had flat or increased ige levels.4 in a randomized, double-blind, placebo controlled study of symptoms and serum ige levels in san diego, ca in mid-1991, subjects had allergic rhinitis and/or asthma. serum was drawn at day 0 and day 30. seven of the 10 active treated subjects had a reduction in total serum ige levels. in 10 placebo treated subjects, 5 had levels suppliers of total serum ige that stayed the same (plus or minus 5%), 3 decreased and 2 increased.5 statistical analysis of the open-label study as well nutritional supplement wholesale as the double-blind randomized placebo controlled study have shown a significant effect of vitamin b12 supplement in lowering suppliers serum ige concentrations.